Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 2 | |
Outperform | 4 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 7 analysts offering 12 month price targets for Arcutis Biotherapeutics Inc have a median target of 19.00, with a high estimate of 27.00 and a low estimate of 12.00. The median estimate represents a 87.38% increase from the last price of 10.14.
High | 166.3% | 27.00 |
Med | 87.4% | 19.00 |
Low | 18.3% | 12.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 01, 2024.
Average growth rate | +15.69% |
Average growth rate | +17.78% |
More ▼
Revenue history & estimates in USD
Average growth rate | +199.62% |
Average growth rate | +505.70% |
More ▼